We profiled CreXus Investment Corp. (NYSE: CXS) at $8.60/share on September 21st as a speculative buying opportunity. CXS topped to $9.31 today for a potential gain of 7.6% in just 2 trading sessions!
Did you convinced for trading stock markets with us? Not yet? Well, yesterday we reported SIGA Technologies, Inc. (Nasdaq: SIGA) as a bounce play. This morning SIGA’s shares jumped to $3.20 from the $2.69 closing share price. Result is:
18% in profits for 45min of trading
Once again: use the current economical conditions of lowering rates for long term mortgages, look for the best mortgage deals around, refinance your property to free up some cash for trading and… trade smart – trade with us!
Above mentioned companies:
CreXus acquires, manages and finances, directly or through its subsidiaries, commercial mortgage loans and other commercial real estate-related debt, commercial real property, commercial mortgage-backed securities, other commercial real estate-related assets and, to the extent necessary for regulatory purposes, residential mortgage-backed securities for remortgage deals. CreXus principal business objective is to provide attractive risk-adjusted returns to our investors over the long-term, primarily through dividends and secondarily through capital appreciation.
35 East 62nd Street
New York, NY 10065
SIGA designs and develops novel countermeasures to prevent and treat serious infectious diseases, with an emphasis on biological warfare and bioterror defense. SIGA is now considered a leading drug development company in the biodefense arena. Its portfolio of existing drug candidates and its platform for developing additional countermeasures against potential agents of biological warfare and bioterror are intended to fill a critical need for safe and effective treatments.